Capecitabine in the treatment of metastatic colorectal cancer.

被引：0
|
作者：
Brockmann, B [1 ]
Magacz, A [1 ]
Bierig, S [1 ]
Kraube, K [1 ]
机构：
[1] Onkol Klin Humaine, Dresden, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Capecitabine-based chemotherapy for metastatic colorectal cancer
    Ling, Wei
    Fan, Jie
    Ma, Yue
    Ma, Yuan
    Wang, Hongxia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 927 - 938
  • [42] Results of bevacizumab biosimilar compared with RMP for the treatment of metastatic colorectal cancer.
    Roca, Enrique Luis
    Vinnyk, Yuriy
    Bondarenko, Igor
    Shparyk, Yaroslav V.
    Bariani, Giovanni Mendonca
    Abdalla, Kathia
    Franke, Fabio
    Cruz, Felipe
    Romera, Alvaro
    Bhannare, Sulabhchandra
    Sudalaiandi, Suresh
    Ostwal, Vikas S.
    Shah, Pradeep
    Rahuman, Sajeed
    Cubillo, Antonio
    Huerga, Camino
    Paravisini, Alexandra
    Fernandez, Francisco Javier
    Milian, Susana
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Capecitabine monotherapy in metastatic colorectal cancer - Effectiveness as first, second and third line treatment
    Schaberl-Moser, Renate
    Bauernhofer, Thomas
    Halm, Michael
    Pirchmoser, Renate
    Samonigg, Hellmut
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [44] A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
    Wong, Nan Soon
    Fernando, Nishan H.
    Nixon, Andrew B.
    Cushman, Stephanie
    Aklilu, Mebea
    Bendell, Johanna C.
    Morse, Michael A.
    Blobe, Gerard C.
    Ashton, Jill
    Pang, Herbert
    Hurwitz, Herbert I.
    ANTICANCER RESEARCH, 2011, 31 (01) : 255 - 261
  • [45] Capecitabine plus oxaliplatin in the treatment of metastatic colorectal cancer at Tygerberg Hospital: a retrospective study
    Kibudde, Solomon
    Begg, Waleed
    PAN AFRICAN MEDICAL JOURNAL, 2022, 42
  • [46] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Wenhua Li
    Jianming Xu
    Lin Shen
    Tianshu Liu
    Weijian Guo
    Wen Zhang
    Zhiyu Chen
    Xiaodong Zhu
    Jin Li
    BMC Cancer, 14
  • [47] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Li, Wenhua
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Weijian
    Zhang, Wen
    Chen, Zhiyu
    Zhu, Xiaodong
    Li, Jin
    BMC CANCER, 2014, 14
  • [48] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [49] Monoinstitutional retrospective analysis of metronomic capecitabine (mc) schedule in the treatment of metastatic colorectal cancer
    Borgonovo, K. F.
    Petrelli, F.
    Cabiddu, M.
    Ghilardi, M.
    Cremonesi, M.
    Barni, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
12345